February 4, 2016
As President Obama’s nominee for FDA Commissioner, former Duke University researcher Robert Califf has faced questions about the independence of clinical trials he conducted for drug companies.
At a confirmation hearing in November and in a written response to later questions from Senator Elizabeth Warren (D-MA), Califf offered comforting answers. He said that plans for clinical trials are subject to FDA review.
But those answers omitted some history that might be less reassuring: a clinical trial Califf had co-chaired was conducted in defiance of FDA guidance.[FULL ARTICLE]